197 related articles for article (PubMed ID: 4136722)
1. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies.
Reedman BM; Klein G; Pope JH; Walters MK; Hilgers J; Singh S; Johansson B
Int J Cancer; 1974 Jun; 13(6):755-63. PubMed ID: 4136722
[No Abstract] [Full Text] [Related]
2. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.
Lindahl T; Klein G; Reedman BM; Johansson B; Singh S
Int J Cancer; 1974 Jun; 13(6):764-72. PubMed ID: 4137165
[No Abstract] [Full Text] [Related]
3. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.
Huang DP; Ho JH; Henle W; Henle G
Int J Cancer; 1974 Nov; 14(5):580-8. PubMed ID: 4142471
[No Abstract] [Full Text] [Related]
4. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
[No Abstract] [Full Text] [Related]
5. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.
Reedman BM; Klein G
Int J Cancer; 1973 May; 11(3):499-520. PubMed ID: 4133943
[No Abstract] [Full Text] [Related]
6. Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures.
Gerber P; Deal DR
Proc Soc Exp Biol Med; 1970 Jul; 134(3):748-51. PubMed ID: 4914465
[No Abstract] [Full Text] [Related]
7. Localization of complement-fixing antigens in cells: Epstein-Barr virus-induced membrane and interior cell antigens.
Hollinshead A; Lee O; Alford TC
J Gen Virol; 1971 Dec; 13(3):441-7. PubMed ID: 4334299
[No Abstract] [Full Text] [Related]
8. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies.
Hilgers F; Rosén A; Lamon E; Klein G
J Natl Cancer Inst; 1974 Oct; 53(4):949-55. PubMed ID: 4372371
[No Abstract] [Full Text] [Related]
9. Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines.
Vonka V; Benyesh-Melnick M; McCombs RM
J Natl Cancer Inst; 1970 Apr; 44(4):865-72. PubMed ID: 11515054
[No Abstract] [Full Text] [Related]
10. Two different complement fixing antigens found in the Burkitt lymphoma cell cultures. Brief report.
Shigeta S; Minowada J; Moore GE
Arch Gesamte Virusforsch; 1971; 33(1):182-6. PubMed ID: 4325972
[No Abstract] [Full Text] [Related]
11. Association of Epstein-Barr virus and American Burkitt's lymphoma.
Easton JM; Ablashi DV; Levine PH; Armstrong GR
IARC Sci Publ (1971); 1975; (11 Pt 2):37-43. PubMed ID: 191381
[No Abstract] [Full Text] [Related]
12. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis.
Hewetson JF; Rocchi G; Henle W; Henle G
J Infect Dis; 1973 Sep; 128(3):283-9. PubMed ID: 4353929
[No Abstract] [Full Text] [Related]
13. Epstein-Barr virus infections.
Middleton PJ
Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
[No Abstract] [Full Text] [Related]
14. An immuno-electron microscopic analysis of Epstein-Barr virus-related antigens in Burkitt lymphoma cells.
Suzuki I
Gan; 1972 Oct; 63(5):629-31. PubMed ID: 4345632
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
Sugawara K; Mizuno F; Osato T
Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
[No Abstract] [Full Text] [Related]
16. Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens.
Dölken G; Gier A; Finke J; Weitzmann U
Ric Clin Lab; 1982; 12(1):307-12. PubMed ID: 6283618
[No Abstract] [Full Text] [Related]
17. Some observations on complement-fixing antibodies to the EB virus.
Sutton RN; Marston SD; Emond RT
J Clin Pathol; 1971 Dec; 24(9):801-4. PubMed ID: 4334546
[TBL] [Abstract][Full Text] [Related]
18. Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells.
Gunvén P; Klein G; Onyango J; Henle G; Henle W; Clifford P; Singh S; Demissie A; Svedmyr A
J Natl Cancer Inst; 1973 Jul; 51(1):45-56. PubMed ID: 4352753
[No Abstract] [Full Text] [Related]
19. An Epstein-Barr virus-negative B lymphoma cell line (THP-2) from a Burkitt's lymphoma of a Japanese patient.
Tsuchiya S; Yamaguchi Y; Kobayashi Y; Minegishi M; Imaizumi M; Suzuki H; Konno T; Tada K
Tohoku J Exp Med; 1983 Aug; 140(4):429-34. PubMed ID: 6314596
[TBL] [Abstract][Full Text] [Related]
20. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
Rocchi G; Hewetson J; Henle W
Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
